ArticleJournal of pharmacy & bioallied sciences2025
A Comparative Study of Platelet-Rich Plasma V/S Corticosteroid Injection for Plantar Fasciitis.
Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Plantar fasciitis, a chronic inflammatory condition characterized by heel pain, significantly impacts daily functioning. While corticosteroid injections are a common treatment, they are associated with limitations such as short-term efficacy and potential complications. Materials and Methods: This prospective interventional study was conducted at Mahatma Gandhi Medical College and Research Institute, Puducherry, between August 2022 and May 2024. A total of 60 patients diagnosed with plantar fasciitis, aged 18-70 years, were randomly divided into two groups: the platelet-rich plasma (PRP) group (30 patients) and the corticosteroid group (30 patients). PRP therapy was administered using the peppering technique, while the corticosteroid group received 80 mg methylprednisolone injections. Pain and functional outcomes were assessed at baseline, second, fourth, eighth, and 12 Results: The mean age of participants was 47.30 ± 10.75 years in the PRP group and 46.13 ± 10.58 years in the corticosteroid group. Females constituted 53.3% of the PRP group and 60% of the corticosteroid group. Significant reductions in VAS scores were observed in the PRP group compared to the corticosteroid group at the second week (5.53 ± 0.776 vs. 6.47 ± 0.937, Conclusion: PRP therapy is a superior alternative to corticosteroid injections for the management of plantar fasciitis, providing sustained pain relief and improved functional outcomes over a 12-week period. Further large-scale, long-term studies are recommended to validate these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.